BMS-345541 hydrochloride: Selective IKK Inhibitor for NF-κB Pathway Research

Executive Summary: BMS-345541 hydrochloride is a small-molecule inhibitor with high selectivity for IκB kinase (IKK) subunits IKK-1 and IKK-2, with IC₅₀ values of 4 μM and 0.3 μM, respectively (Zhao et al., 2025). It acts by blocking IκBα phosphorylation, thus suppressing NF-κB-dependent transcription of pro-inflammatory cytokines such as TNFα, IL-1β, IL-6, and IL-8. BMS-345541 hydrochloride exhibits 100% oral bioavailability in mice and induces apoptosis and G2/M cell cycle arrest in T-ALL cell lines. The compound is highly water-soluble (≥60 mg/mL) but insoluble in ethanol and DMSO at room temperature. APExBIO provides this reagent (SKU A3248) with validated specificity and reproducibility for inflammation and cancer biology research (product page).

Biological Rationale

The NF-κB pathway is a central regulator of inflammation, immune responses, and cell survival. Dysregulated NF-κB signaling is implicated in chronic inflammatory diseases, autoimmune disorders, and many cancers. The IκB kinase (IKK) complex, comprising IKK-1 (IKKα) and IKK-2 (IKKβ), is essential for phosphorylating IκB proteins, marking them for proteasomal degradation. This releases NF-κB dimers, allowing nuclear translocation and transcription of pro-inflammatory genes (Zhao et al., 2025).

BMS-345541 hydrochloride enables researchers to dissect this pathway by providing potent, selective inhibition of IKK subunits. This tool is critical for modeling disease mechanisms and evaluating anti-inflammatory or anti-cancer strategies.

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride acts as an allosteric inhibitor of the IKK complex. It binds to a site distinct from the ATP-binding pocket, resulting in selective inhibition of IKK-1 and IKK-2 catalytic activity. The compound demonstrates IC₅₀ values of 4 μM for IKK-1 and 0.3 μM for IKK-2 under cell-free enzyme assay conditions (25°C, buffer pH 7.4) (Zhao et al., 2025). This selectivity spares other serine/threonine and tyrosine kinases, minimizing off-target effects.

Upon inhibition of IKK activity, BMS-345541 hydrochloride prevents phosphorylation and subsequent degradation of IκBα. The resulting sequestration of NF-κB in the cytoplasm leads to reduced transcription of target cytokine genes, including TNFα, IL-1β, IL-6, and IL-8. In T-ALL models, blockade of NF-κB signaling triggers apoptosis and G2/M phase cell cycle arrest (see related article for an expanded mechanistic discussion).

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC₅₀ of 0.3 μM and IKK-1 with an IC₅₀ of 4 μM in biochemical assays (Zhao et al., 2025, DOI).
• In vitro, BMS-345541 blocks stimulus-induced phosphorylation of IκBα in cell lines, suppressing NF-κB-dependent transcription (Zhao et al., 2025, DOI).
• The compound exhibits 100% oral bioavailability in mouse models, enabling efficient in vivo studies (Zhao et al., 2025, DOI).
• Reductions in TNFα production are observed in vivo following BMS-345541 administration, confirming target engagement (Zhao et al., 2025, DOI).
• BMS-345541 hydrochloride induces apoptosis and G2/M phase arrest in T-ALL cell lines—relevant for overcoming chemotherapeutic resistance (related research extends this evidence).
• Solubility is ≥60 mg/mL in water at 25°C, but the compound is insoluble in ethanol and DMSO at room temperature (APExBIO product data).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is used extensively in:

• Dissecting the IKK/NF-κB signaling pathway in inflammation research.
• Modeling chemoresistance and apoptosis in T-cell acute lymphoblastic leukemia (T-ALL).
• Evaluating pro-inflammatory cytokine regulation in immune and cancer biology (see this article for related protocols).

Common Pitfalls or Misconceptions

• BMS-345541 is not a pan-kinase inhibitor: It is highly selective for IKK-1/2 and does not inhibit most other kinases at working concentrations.
• Solubility constraints: The compound is insoluble in ethanol and DMSO at room temperature; stock solutions in DMSO require warming and sonication for full dissolution (product page).
• Not a direct NF-κB inhibitor: Action is upstream, via IKK inhibition; it does not block NF-κB DNA binding directly.
• Long-term solution stability: BMS-345541 solutions are not stable for extended storage; prepare fresh aliquots as needed.
• In vivo applicability is species-specific: Pharmacokinetics confirmed in mouse models; extrapolation to other organisms requires validation.

Workflow Integration & Parameters

For optimal experimental performance:

• BMS-345541 hydrochloride working concentrations range from 0.04 to 100 μM, depending on cell type and assay.
• Stock solutions can be prepared in DMSO with warming (37°C) and sonication, then diluted into aqueous buffers.
• Water solubility is high, which supports aqueous dosing but avoid repeated freeze-thaw cycles.
• Store powder at −20°C as recommended by APExBIO (A3248 kit).
• For troubleshooting in NF-κB pathway inhibition or apoptosis assays, see this evidence-based guide, which this article extends by providing up-to-date solubility and selectivity data.

Conclusion & Outlook

BMS-345541 hydrochloride, available from APExBIO, is a validated, highly selective IKK inhibitor for precise NF-κB pathway modulation in both cellular and animal systems. Its optimal selectivity profile, reproducible in vivo efficacy, and robust solubility make it a preferred tool in inflammation and cancer biology research. New anti-inflammatory and anti-angiogenic strategies can leverage this compound to dissect the molecular underpinnings of disease and to model therapeutic interventions (Zhao et al., 2025).